Prostate Specific Antigen Levels and Prostate Cancer Risk

Age-Specific Normal PSA Ranges

The American Urological Association suggests that normal PSA levels vary by age and ethnicity, with age-specific reference ranges being 0-2.0 ng/mL for Asian-Americans and African-Americans aged 40-49, and 0-2.5 ng/mL for Whites in the same age group, with progressive increases in normal ranges for older age groups 1, 2
For men aged 40-49, normal PSA levels are 0-2.0 ng/mL for Asian-Americans and African-Americans, and 0-2.5 ng/mL for Whites 1, 2, 3
For men aged 50-59, normal PSA levels are 0-3.0 ng/mL for Asian-Americans, 0-4.0 ng/mL for African-Americans, and 0-3.5 ng/mL for Whites 1, 2, 3
For men aged 60-69, normal PSA levels are 0-4.0 ng/mL for Asian-Americans, 0-4.5 ng/mL for African-Americans, and 0-4.5 ng/mL for Whites 1, 2, 3
For men aged 70-79, normal PSA levels are 0-5.0 ng/mL for Asian-Americans, 0-5.5 ng/mL for African-Americans, and 0-6.5 ng/mL for Whites 1, 2, 3

Median PSA values in cancer-free men are 0.7 ng/mL for men in their 40s, 0.9 ng/mL for men in their 50s, 1.2 ng/mL for men in their 60s, and 1.5 ng/mL for men in their 70s 1, 2, 3, 4

The risk of prostate cancer increases with PSA level, with a 6.6% risk of prostate cancer for PSA 0-0.5 ng/mL, 10.1% risk for PSA 0.6-1.0 ng/mL, 17.0% risk for PSA 1.1-2.0 ng/mL, 23.9% risk for PSA 2.1-3.0 ng/mL, and 26.9% risk for PSA 3.1-4.0 ng/mL 1, 4

A rise of 0.75 ng/mL or greater in a year is concerning for men with PSA levels ≤4.0 ng/mL 1, 2
Age-adjusted PSA velocity thresholds are 0.25 ng/mL/year for men aged 40-59, 0.5 ng/mL/year for men aged 60-69, and 0.75 ng/mL/year for men aged 70+ 1, 2, 4

Laboratory variability can range from 20-25% depending on the standardization method used 2, 5
For longitudinal monitoring, the same PSA assay should be used as there is no acknowledged conversion factor between different assays 2, 5
Factors that can affect PSA levels include prostatitis, benign prostatic hyperplasia, urethral/prostatic trauma, finasteride, dutasteride, and prostate biopsy 5

The American Urological Association recommends an individualized risk assessment approach for prostate biopsy decisions, considering factors such as PSA level, digital rectal examination results, free and total PSA, patient age, PSA velocity, PSA density, family history, ethnicity, prior biopsy history, and comorbidities 3, 4